EP006 — The Empty File (FDA Regulation, Part 1 of 2)

Why is one peptide in your morning smoothie and another one a grey-market gamble — when they’re both just peptides? Part one of our two-part regulatory deep dive traces how America decides what counts as a food, a supplement, or a drug, where peptides fall in that system, and what a major FDA advisory meeting can — and can’t — actually change. The molecules didn’t change. The rules did.

Link To Services

In this episode

A plain-English history of how the U.S. regulates what goes into your body — built to make sense of the FDA compounding meeting the whole peptide world was watching.
•The cold open: two peptides, one in a health-food aisle and one underground — and why the only real difference is the statute.
•A quick, non-boring history of drug regulation and the approval pathways peptides are forced to fit through.
•Peptides vs. vitamins: same “it’s just a supplement” instinct, wildly different rulebooks.
•What “Category 1” and “Category 2” actually mean — and what really stops your doctor from prescribing (often insurance, not law).
•Foreign research: why data from abroad frequently can’t cross the border, and why that’s structural rather than a conspiracy.
•“Phantom authority” — the fake citations and confidently-wrong sources that pollute this space, and how to spot them.
•What the advisory meeting is, isn’t, and could realistically change.

Part one sets the board. Part two picks up with what actually happened in the room.

Everything discussed on this show is for informational and educational purposes only, based on published research and community-reported experience. We are not doctors, and nothing here constitutes medical advice. Our goal is simple: to give you enough information to have a real, informed conversation with your own physician — one where you walk in knowing the right questions to ask. Please involve a qualified healthcare provider before making any changes to your health protocols. Don’t skip that step.

EP005 — Cosmetic & Skin Peptides

The peptides already in your serum — and the ones people inject for their skin, tan, and hair. We split the topical “Botox-in-a-bottle” ingredients (Argireline, Matrixyl, Snap-8) from the injectables (GHK-Cu, Epithalon, the Melanotans), explain why that line decides what’s even legal, and get honest about the tanning peptide with a genuinely alarming safety file. Vanity, meet evidence.

Link To Services

In this episode

From the peptides already in your skincare to the ones the community injects — and the bright line between “cosmetic” and “drug” that decides which is which.
•Topical vs. injectable: the regulatory split that explains why some of these sit on a shelf and others live in a vial.
•The serum shelf — Argireline, Matrixyl, Snap-8 — and what “expression-line” peptides genuinely can and can’t do.
•GHK-Cu and the copper peptides: the category’s most credible player.
•The Melanotans — the tanning peptides — and the real, documented safety problems we don’t gloss over.
•Epithalon, MOTS-c, SS-31: the “longevity” crossover, and where the human evidence actually stands.
•Loose skin after big GLP-1 weight loss — the cold-open question that kicks the whole episode off.
The most-marketed corner of the peptide world, sorted into what’s proven, what’s promising, and what’s just packaging.

Everything discussed on this show is for informational and educational purposes only, based on published research and community-reported experience. We are not doctors, and nothing here constitutes medical advice. Our goal is simple: to give you enough information to have a real, informed conversation with your own physician — one where you walk in knowing the right questions to ask. Please involve a qualified healthcare provider before making any changes to your health protocols. Don’t skip that step.

EP004 — Growth Hormone

Instead of injecting growth hormone, what if you could nudge your body into making more of its own? That’s the pitch behind secretagogues — and this episode unpacks how they actually work. We cover the big four (CJC-1295, Ipamorelin, Sermorelin, Tesamorelin), the ghrelin pathway they hijack, the only one the FDA has actually approved, and why so much of the “data” online about them is quietly wrong.

Link To Services

In this episode

The category that promises to turn up your own growth hormone — how the machinery works, and where the marketing outruns the evidence.
•Two ways in: GHRH analogs vs. ghrelin-pathway peptides — and why pairing them is the classic stack.
•The big four — CJC-1295, Ipamorelin, Sermorelin, Tesamorelin — including the one that’s outright illegal for human use, and the one the FDA has actually approved.
•Growth hormone itself vs. the peptides that trigger it: why they aren’t really the same category.
•The fragments — AOD-9604 and HGH Fragment 176-191 — and the molecular mix-up between them people constantly get wrong.
•A myth-busting detour on bioavailability, where a widely-shared clinic figure turned out to be off by more than tenfold.
How to tell the mechanism from the marketing, before this one ever comes up with your doctor.
Everything discussed on this show is for informational and educational purposes only, based on published research and community-reported experience. We are not doctors, and nothing here constitutes medical advice. Our goal is simple: to give you enough information to have a real, informed conversation with your own physician — one where you walk in knowing the right questions to ask. Please involve a qualified healthcare provider before making any changes to your health protocols. Don’t skip that step.